Biotech Steals The Show Following Pre-Clinical Data Announcement
27 Marzo 2024 - 1:35PM
AllPennyStocks.com
A California-based biotech company stirred
things up on Wednesday after it was announced the publication of
preclinical data on its lead clinical compound, LB-100.
To read the full story on AllPennyStocks.com, click
here.
Lixte Biotechnology (NASDAQ:LIXT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Lixte Biotechnology (NASDAQ:LIXT)
Gráfica de Acción Histórica
De May 2023 a May 2024